MORRISVILLE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its third FDA inspection, further ...

Science 37 is a leading patient access company in clinical research that delivers trials directly to patients' homes.

PAI took place over four days for an API that the Malvern, PA site will manufacture for a global pharma company.

Watchdog groups report that while the number of regulated facilities has increased, the volume of inspections has ...

The FDA has made additional reports on inspections of ByHeart infant formula plants available. The company’s formula has been determined to be the source of at least 37 cases of infant botulism. The ...